As an example, the binding of a small molecule to the proline-rich sequences of MYND may be possible in cells where the tumor suppressor EBP41L3 links to SMYD2, as is the case in meningiomas, a brain cancer, and lung cancer [10,23,99,100]. This evidence concerns the gene SMYD2 and lung carcinoma.